Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Tirzepatide for Sale > FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99%
FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99% buy - large image1
FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99% buy - image1
FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99% buy - image2
FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99% buy - image3
FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99% buy - image4
FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99% buy - image5
FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99% buy - image6

FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99%

TDS 1782 Inquiries

Unit Price:

$150-190/G EXW

Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Content:

99.3%

Packaging:

vials Cartridge APIs

Price valid (until):

2027-04-07

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Retatrutide,Tirzepatide,Semaglutide,TB500,HGH Fragment 176-191,GHK-Cu (Copper Peptide)

  • Product Description

  • Seller Information

  • Inquiry History

  • Description
    Items Specifications
    Tirzepatide vials 5mg 10mg  15mg  20mg  30mg  40mg  60mg 
    Tirzepatide Cartridge 5mg 10mg  15mg  20mg  30mg  40mg  60mg 
    Tirzepatide APIs g kg


    Shop FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99%-Detailed Image 1

    Year of Establishment: 2019 | Business Type: Manufactory

    Name: Mark

    WhatsApp:+60 11-2177 6267

    WeChat: Mark601121776267

    Email: wukongceob2b@gmail.com


    Tirzepatide (LY3298176) is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.

    This medication is designed to improve glycemic control in people with type 2 diabetes by targeting both the GIP and GLP-1 receptors. By stimulating these receptors, tirzepatide can increase insulin secretion and decrease glucagon secretion in a glucose-dependent manner, helping to lower blood sugar levels.

    Clinical trials have shown promising results in terms of reducing HbA1c levels and body weight in individuals with type 2 diabetes. Tirzepatide is being studied in various dosages and formulations to determine its effectiveness, safety, and potential benefits for people with diabetes

    NOTE: This product was prepared by chemical synthesis. Used only for research. Not for human use.





    Shop FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99%-Detailed Image 2

    Our headquarters is located in the Xiasha Economic Development Zone in Hangzhou, China. Our research team has nearly 20 years of experience in peptide research and development. We have completed international applications for multiple products and have extensive experience in ANDA marketing for complex formulations in the United States, Europe, Japan, and other regions.






    The company is positioned as an international-level peptide delivery platform. It has research bases in China and the United States and adopts international R&D standards to provide customers with one-stop solutions for peptide products. Provide customers with technology development and international filing and registration services for new peptide products, a full set of peptide impurities, and consistency evaluation. At the same time, the company has established a scientific and complete peptide research and development system and a quality assurance system that meets international application requirements to ensure the scientificity and compliance of project research and development.



    Certificates
    • FDA registered Tirzepatide Cartridge CAS NO: 2023788-19-2 purity 99% Certificates 1

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Other Chemical Drugs

    Characteristics
    Appearance:

    White to off-white

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Retatrutide,Tirzepatide,Semaglutide,TB500,HGH Fragment 176-191,GHK-Cu (Copper Peptide)

    Location:

    1-1, Building 19, No. 78, Shengli Road, Xinzhou District, Shangrao City, Jiangxi Province

    Payment Terms:

    100% TT in advance

    Average lead Time:

    7

    Total Employees:

    Above 1000

    Year of Establishment:

    2023

    Certifications:

    GMP,FDA,Semaglutide COA,Tirzepatide COA,Retatrutide COA

    Company Profile

    Many of our products have obtained DMF registration from the US FDA, and our team of peptide experts has extensive experience in peptide research and development. Products have successfully landed in China, the United States, Europe, Japan and other markets. ThinHeal is committed to building an international peptide delivery system and providing customers with one-stop service..
    The company is positioned as an international-level peptide delivery platform. It has research bases in China and the United States and adopts international R&D standards to provide customers with one-stop solutions for peptide products. Provide customers with technology development and international filing and registration services for new peptide products, a full set of peptide impurities, and consistency evaluation. At the same time, the company has established a scientific and complete peptide research and development system and a quality assurance system that meets international application requirements to ensure the scientificity and compliance of project research and development.
    The scientific research team has nearly 20 years of experience in peptide research and development, has completed international applications for multiple varieties, and has rich marketing experience in complex preparations ANDA in the United States, Europe, Japan and other places.

    The company has built an international R&D standard experimental platform of nearly 2,000 square meters, equipped with advanced instruments and equipment such as waters high-performance liquid chromatography, mass spectrometry system, gas chromatograph, freeze dryer, etc. to ensure the scientific and orderly progress of R&D projects.

    Doctors are benevolent, and benevolent people are trustworthy. The sea accepts all rivers, and tolerance is great. ThinHeal Pharma adheres to the concepts of pragmatism, integrity and inclusiveness, actively promotes the development and innovation of the peptide industry, and provides accessible solutions to the majority of patients!

    Core advantages

    1. Complete quality management system: The company has established a quality management system covering the entire life cycle of peptide based on China GMP, 21CFR Part 210, 211, EU cGMP Volume 4, and ICH guideline, providing comprehensive and complete quality assurance for the entire product process.

    2. Mature project management advantages: In terms of project management, the team fully implements the ICH guideline requirements according to customer needs. The team has high-end peptide research and development experience and international application experience to ensure the smooth development of the project.

    3. Solid cGMP management advantages: The team has rich cGMP management experience and implements cGMP management for product transfer, process verification and commercial production according to the requirements of different declaration places (including China, the United States, the European Union, and Japan).

    4. Advantages of cost control management: From peptide synthesis route selection, purification process optimization to full-process quality control, we always put customer interests first and achieve effective cost control while ensuring product quality and regulatory compliance.

     5. Mature process development technology: platform-based peptide process development technology.

    In terms of peptide raw materials: up to 40 peptide synthesis experiences, including but not limited to the synthesis of linear peptides/cyclic peptides/polypeptide products containing multiple disulfide bonds; solid phase/liquid phase peptide synthesis and assembly coupling; peptide modification and polypeptide synthesis Cyclic peptide synthesis.

    Peptide preparations: including process development and quality control of peptide injections, peptide oral sustained-release preparations, and long-acting peptide injections, as well as experience in stability research and scale-up production.



  • Inquiry History
    1782 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Tirzepatide CAS 2023788-19-2 99% White powder

    Jun 30, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Tirzepatide 99% white powder 99% powder 2023788-19-2 HSD

    1000 G Jun 27, 2023
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    50  Aug 17, 2023
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    10  Aug 3, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    United States

    Buy Tirzepatide 5mg 10mg 15mg Great Reviews 2023788-19-2 99% powder 001 HD

    1 KG Jul 3, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.